The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

This is the core challenge that agentic identity aims to solve. In simple terms, agentic identity is a framework for binding ...

AI in 2025 shifted from hype to economics, defined by compute, energy, infrastructure limits, enterprise adoption, and ...

If hundreds of thousands of ballots in Georgia’s pivotal 2020 election lacked legally required certification, then calling it ...

Medicus Pharma (MDCX) entered into non-binding letter of intent with Reliant AI to collaborate on the development of an ...

There's just not enough time to cover them all, and 2025 was packed with gems you probably haven't heard of. For those ...

Agentic AI challenges the foundational tenets of our legal frameworks, which have historically relied on clear lines of ...

Before splurging on non-essentials, do a review of your basic needs, suggests Andi Wrenn, an accredited financial counselor ...

KOFST has been selecting and announcing the 'Top 10 Science and Technology News' annually since 2005 to raise public interest ...

Europe is unlikely to lift energy sanctions regardless of a deal, keeping long-term oil market impacts muted and Russian ...

Two arrested at Jerusalem protest marking 5 years since settler teen killed in police chase * Ex-police chief lambasts PM's ...

At the recent ELRIG Drug Discovery conference, Technology Networks<i/> spoke with Dr. Kundan Sharma to learn more about how cell-free expression platforms are transforming membrane protein research.